Cargando…
Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk: a single-center study
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309505/ https://www.ncbi.nlm.nih.gov/pubmed/37185356 http://dx.doi.org/10.1097/CM9.0000000000002399 |
| _version_ | 1785066454871179264 |
|---|---|
| author | Chai, Meng Zhang, Haitao Yang, Lixia Liang, Jing Han, Hongya Liu, Xiaoli Ma, Xiaoteng Liu, Yan Shi, Dongmei Zhao, Yingxin Liu, Yuyang Zhou, Yujie |
| author_facet | Chai, Meng Zhang, Haitao Yang, Lixia Liang, Jing Han, Hongya Liu, Xiaoli Ma, Xiaoteng Liu, Yan Shi, Dongmei Zhao, Yingxin Liu, Yuyang Zhou, Yujie |
| author_sort | Chai, Meng |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10309505 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103095052023-06-30 Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk: a single-center study Chai, Meng Zhang, Haitao Yang, Lixia Liang, Jing Han, Hongya Liu, Xiaoli Ma, Xiaoteng Liu, Yan Shi, Dongmei Zhao, Yingxin Liu, Yuyang Zhou, Yujie Chin Med J (Engl) Clinical Observation Lippincott Williams & Wilkins 2023-06-05 2023-04-25 /pmc/articles/PMC10309505/ /pubmed/37185356 http://dx.doi.org/10.1097/CM9.0000000000002399 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Clinical Observation Chai, Meng Zhang, Haitao Yang, Lixia Liang, Jing Han, Hongya Liu, Xiaoli Ma, Xiaoteng Liu, Yan Shi, Dongmei Zhao, Yingxin Liu, Yuyang Zhou, Yujie Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk: a single-center study |
| title | Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk: a single-center study |
| title_full | Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk: a single-center study |
| title_fullStr | Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk: a single-center study |
| title_full_unstemmed | Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk: a single-center study |
| title_short | Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk: a single-center study |
| title_sort | lipid lowering effects and safety of evolocumab in chinese patients at very high cardiovascular risk: a single-center study |
| topic | Clinical Observation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309505/ https://www.ncbi.nlm.nih.gov/pubmed/37185356 http://dx.doi.org/10.1097/CM9.0000000000002399 |
| work_keys_str_mv | AT chaimeng lipidloweringeffectsandsafetyofevolocumabinchinesepatientsatveryhighcardiovascularriskasinglecenterstudy AT zhanghaitao lipidloweringeffectsandsafetyofevolocumabinchinesepatientsatveryhighcardiovascularriskasinglecenterstudy AT yanglixia lipidloweringeffectsandsafetyofevolocumabinchinesepatientsatveryhighcardiovascularriskasinglecenterstudy AT liangjing lipidloweringeffectsandsafetyofevolocumabinchinesepatientsatveryhighcardiovascularriskasinglecenterstudy AT hanhongya lipidloweringeffectsandsafetyofevolocumabinchinesepatientsatveryhighcardiovascularriskasinglecenterstudy AT liuxiaoli lipidloweringeffectsandsafetyofevolocumabinchinesepatientsatveryhighcardiovascularriskasinglecenterstudy AT maxiaoteng lipidloweringeffectsandsafetyofevolocumabinchinesepatientsatveryhighcardiovascularriskasinglecenterstudy AT liuyan lipidloweringeffectsandsafetyofevolocumabinchinesepatientsatveryhighcardiovascularriskasinglecenterstudy AT shidongmei lipidloweringeffectsandsafetyofevolocumabinchinesepatientsatveryhighcardiovascularriskasinglecenterstudy AT zhaoyingxin lipidloweringeffectsandsafetyofevolocumabinchinesepatientsatveryhighcardiovascularriskasinglecenterstudy AT liuyuyang lipidloweringeffectsandsafetyofevolocumabinchinesepatientsatveryhighcardiovascularriskasinglecenterstudy AT zhouyujie lipidloweringeffectsandsafetyofevolocumabinchinesepatientsatveryhighcardiovascularriskasinglecenterstudy |